Liminatus Pharma, Inc. (LIMN)

NASDAQ: LIMN · Real-Time Price · USD
12.80
-0.01 (-0.08%)
At close: Jun 18, 2025, 4:00 PM
13.14
+0.34 (2.66%)
After-hours: Jun 18, 2025, 7:58 PM EDT
-0.08%
Market Cap 332.99M
Revenue (ttm) n/a
Net Income (ttm) -3.55M
Shares Out 26.01M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 122,836
Open 13.71
Previous Close 12.81
Day's Range 12.61 - 13.71
52-Week Range 4.40 - 26.68
Beta 0.17
Analysts n/a
Price Target n/a
Earnings Date n/a

About LIMN

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country United States
Stock Exchange NASDAQ
Ticker Symbol LIMN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.